After defining where automation and AI create value in patient services, the next question is how patient access teams should decide which capability belongs in a given workflow. Patient access programs are under constant pressure to move faster, reduce friction for patients, and support scale without adding cost or risk. As teams look for digital solutions to meet that pressure, automation and artificial intelligence (AI) are often discussed together, but they solve different problems in different ways. Knowing which one fits a given challenge, and when to use both together, is key to building a patient access program that is efficient, compliant, and genuinely helpful to patients.
Automation: Consistency at Scale
Automation is technology built to carry out predefined tasks the same way, every time. It is most effective when the rule is clear: if a certain condition is met, a certain action happens. Because the logic is fixed, automated processes are predictable, auditable, and easier to validate against established business rules, which matters in a space where every step of the patient journey process is defined.
In many patient access programs, automation handles much of this operational groundwork. It can confirm that a enrollment includes all required fields before it moves forward, screen a patient against defined criteria for free goods or copay assistance, route emails, trigger next steps, and manage day-to-day communication workflows based on predefined rules.
None of these examples replace humans where judgment is actually needed. What automation does is remove the repetitive, rules-based work that slows programs down, so case managers and program staff can spend their time on patients who need real support rather than paperwork a system can handle on its own.
AI: Insight in Variable Workflows
AI is built for a different kind of problem: the ones that do not have a clean, fixed rules to follow. Instead of executing a predefined script, many AI systems use machine learning and other techniques to interpret data, recognize patterns, and generate an output, whether that is a written summary, a recommendation, or a conversation. That makes AI useful anywhere a patient access program runs into variability, ambiguity, or the need for real-time interpretation, provided the workflow includes appropriate governance, validation, and human oversight.
Conversational AI agents are a good example. They can take on the “easy,” transactional type of calls, freeing up case managers to focus on the follow-up questions and more complex conversations that patients, caregivers, and healthcare providers actually need a person for. AI can also be used to classify call patterns and topics across large volumes of interactions, surfacing insights into customer sentiment and the issues coming up most often, insights that can directly inform customer experience strategy.
Taken together, AI complements automation by enabling more dynamic, knowledge-driven support in patient access workflows, particularly in the moments where variability and interpretation matter most. In regulated environments, that value depends on clear guardrails, monitoring, escalation paths, and approved use cases rather than assuming AI can operate independently.
Automation or AI?
The real question for patient access teams is not automation or AI. It is knowing which tool fits which problem and applying each thoughtfully based on the use case.
Automation works best for structured, repetitive tasks that follow clear rules and require consistency, making it a dependable, easily validated option in a regulated environment. AI delivers value in more complex, variable scenarios where interpretation, adaptation, or content generation is needed. In many situations, a simple script is enough. In others, an AI-enabled solution unlocks capabilities and insights a script never could.
A balanced approach, one that uses automation for scale and consistency and AI for nuance and insight, helps patient access programs improve efficiency while maintaining compliance, preserving human oversight, and applying advanced technology only where it delivers real, meaningful value for patients.
About UBC
United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. UBC leads the market in providing integrated, comprehensive clinical, safety, and commercialization services and is uniquely positioned to seamlessly integrate best-in-class services throughout the lifecycle of a product.
About the Author
Dana Edwards, Vice President, Patient Access & Strategic Engagement
Dana Edwards serves as the Vice President, Patient Access & Strategic Engagement at UBC. She brings more than 20 years of experience in executing patient service and market access strategies to this role. Ms. Edwards is a strategic advisor to pharmaceutical and biotech leaders on the design and implementation of patient service programs that synchronize the right people, services, and technology for their unique patient population and therapy.
